Nelfinavir plasma concentrations in patients experiencing early failure with nelfinavir-containing triple combinations

Daniel Gonzàlez De Requena, Marina Núñez, Carmen De Mendoza, Inmaculada Jiménez-Nàcher, Vincent Soriano

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Virological failure to protease inhibitor (PI)-based antiretroviral regimens is often not explained by the selection of PI resistance mutations. The role of low PI plasma levels in treatment failure was assessed in 30 patients failing nelfinavir-containing triple combinations. Approximately a third of the patients showed sub-therapeutic nelfinavir plasma levels. More than two-thirds of them had no drug resistance mutations, suggesting that insufficient nelfinavir levels contributed to treatment failure.

Original languageEnglish (US)
Pages (from-to)442-444
Number of pages3
JournalAIDS
Volume17
Issue number3
DOIs
StatePublished - Feb 14 2003

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Nelfinavir plasma concentrations in patients experiencing early failure with nelfinavir-containing triple combinations'. Together they form a unique fingerprint.

Cite this